CAS: 1428569-85-0
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | GDC-0339 REF: 3D-DHC56985CAS: 1428569-85-0 | Min. 95% | A consultar | Mar 18 Jun 24 |
 | GDC-0339 REF: TM-T15376CAS: 1428569-85-0 | - - - | 183,00 €~3.491,00 € | Mar 06 Ago 24 |
GDC-0339
CAS:1428569-85-0
GDC-0339 is a potent inhibitor of the enzyme farnesyltransferase, which is required for the post-translational …
Fórmula:
C20H22F3N7OS
Pureza:
Min. 95%
Peso molecular:
465.5 g/mol
Ref: 3D-DHC56985
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 18 de Junio de 2024
GDC-0339
CAS:1428569-85-0
GDC-0339 is discovered as a potential treatment of multiple myeloma. GDC-0339 is an orally bioavailable …
Fórmula:
C20H22F3N7OS
Forma y color:
Solid
Peso molecular:
465.5
Ref: TM-T15376
| 25mg | 1.531,00 € | |
| 50mg | 2.013,00 € | |
| 100mg | 3.491,00 € |
Entrega estimada en Estados Unidos, el Martes 6 de Agosto de 2024
